IL-6 inhibitors have also been proposed as a treatment option for rare and severe AIDs such as vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome caused by somatic variants in the UBA1 gene (50, 51). Here, IL6 is linked to AIDS.